AEterna Zentaris Inc. (USA)

General ticker "AEZS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.7M

AEterna Zentaris Inc. (USA) does not follow the US Stock Market performance with the rate: -18.5%.

Estimated limits based on current volatility of 2.8%: low 3.71$, high 4.04$

Factors to consider:

  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.33$, 14.06$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.47$, 16.38$]

Financial Metrics affecting the AEZS estimates:

  • Negative: Non-GAAP EPS of -6.89 <= 0.08
  • Negative: Operating Income to Revenue ratio of -0.80 <= 0.01
  • Negative: Operating Cash Flow per share of -3.59 <= 0.20
  • Negative: negative Net Income
  • Negative: Industry Operating Cash Flow per share (median) of -1.55 <= 0.28
  • Positive: Interest Expense per share of 0.03 <= 0.20

Similar symbols

Short-term AEZS quotes

Long-term AEZS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $5.26MM $5.64MM $4.58MM
Operating Expenses $13.93MM $20.89MM $22.92MM
Operating Income $-8.67MM $-15.25MM $-18.34MM
Non-Operating Income $0.19MM $-7.47MM $1.48MM
Interest Expense $0.02MM $0.00MM $0.13MM
R&D Expense $6.57MM $12.51MM $13.81MM
Income(Loss) $-8.48MM $-22.73MM $-16.86MM
Taxes $-0.11MM $14.94MM $0.00MM
Profit(Loss) $-8.37MM $-37.67MM $-16.86MM
Stockholders Equity $52.99MM $35.78MM $18.10MM
Assets $80.10MM $56.03MM $36.83MM
Operating Cash Flow $-8.58MM $-13.68MM $-17.43MM
Investing Cash Flow $-0.66MM $-0.01MM $0.54MM
Financing Cash Flow $51.04MM $-0.12MM $-0.15MM
Earnings Per Share* $-1.82 $-7.76 $-3.47

* EPS are Split Adjusted, recent splits may be reflected with a delay.